NEWS ALERT: Trump’s NIH and FDA nominees advance to full Senate vote

1

For ads-free news, click here.

From the Washington Examiner: Two of President Donald Trump’s key public health nominations advanced at the committee level Thursday morning, moving them to consideration in the full Senate.

The Senate Committee on Health, Education, Labor and Pensions voted on party lines to approve the nominations of Dr. Jay Bhattacharya, the nominee for National Institutes of Health director, and Dr. Marty Makary, the nominee to head the Food and Drug Administration.

Sen. Bill Cassidy (R-LA), the panel’s chairman, said during the vote that public health in the United States is in a precarious position due to a lack of trust in federal health institutions from failed policies during the COVID-19 pandemic.

“To start, we need public health leaders committed to transparency and finding unbiased solutions to Americans’ most challenging health problems,” Cassidy said. “Dr. Bhattacharya and Dr. Makary have demonstrated that they are ready to take on this responsibility.”


The committee voted 14-9 to advance Makary’s nomination, with Democratic senators Maggie Hassan (N.H.) and John Hickenlooper (Colo.) joining Republicans to vote in favor.

The vote for Bhattacharaya was 12-11, with Republicans voting in favor and Democrats opposed.

The nominations now advance to the full Senate, where a GOP majority is expected to confirm them both.

During his confirmation hearing, Bhattacharya said, “Science should be an engine for knowledge and freedom, not something that stands on top of society and says you must do this or else. It shouldn’t be pushing covid vaccines.”

Bhattacharya also vowed to stop all gain-of-function research as NIH Director, saying, “I don’t think the NIH should be doing any research that has the potential to cause a pandemic.”

Follow us on X (Formerly Twitter.)
The DML News App: www.X.com/DMLNewsApp

The Dennis Michael Lynch Podcast archive is available below, with the most recent on top. Never miss an episode. Subscribe to the show by downloading The DML News App or go to Apple Podcasts.

CLICK HERE FOR COMMENTS SECTION